These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
809 related articles for article (PubMed ID: 16423043)
1. Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles. Shen H; Ackerman AL; Cody V; Giodini A; Hinson ER; Cresswell P; Edelson RL; Saltzman WM; Hanlon DJ Immunology; 2006 Jan; 117(1):78-88. PubMed ID: 16423043 [TBL] [Abstract][Full Text] [Related]
2. Surface modification of poly(D,L-lactic-co-glycolic acid) nanoparticles with protamine enhanced cross-presentation of encapsulated ovalbumin by bone marrow-derived dendritic cells. Han R; Zhu J; Yang X; Xu H J Biomed Mater Res A; 2011 Jan; 96(1):142-9. PubMed ID: 21105162 [TBL] [Abstract][Full Text] [Related]
3. Antigen delivery via hydrophilic PEG-b-PAGE-b-PLGA nanoparticles boosts vaccination induced T cell immunity. Rietscher R; Schröder M; Janke J; Czaplewska J; Gottschaldt M; Scherließ R; Hanefeld A; Schubert US; Schneider M; Knolle PA; Lehr CM Eur J Pharm Biopharm; 2016 May; 102():20-31. PubMed ID: 26940132 [TBL] [Abstract][Full Text] [Related]
4. pH-Responsive Poly(D,L-lactic-co-glycolic acid) Nanoparticles with Rapid Antigen Release Behavior Promote Immune Response. Liu Q; Chen X; Jia J; Zhang W; Yang T; Wang L; Ma G ACS Nano; 2015 May; 9(5):4925-38. PubMed ID: 25898266 [TBL] [Abstract][Full Text] [Related]
5. Polymer nanoparticles for cross-presentation of exogenous antigens and enhanced cytotoxic T-lymphocyte immune response. Song C; Noh YW; Lim YT Int J Nanomedicine; 2016; 11():3753-64. PubMed ID: 27540289 [TBL] [Abstract][Full Text] [Related]
6. Biodegradable nanoparticles containing TLR3 or TLR9 agonists together with antigen enhance MHC-restricted presentation of the antigen. Lee YR; Lee YH; Im SA; Yang IH; Ahn GW; Kim K; Lee CK Arch Pharm Res; 2010 Nov; 33(11):1859-66. PubMed ID: 21116790 [TBL] [Abstract][Full Text] [Related]
7. The effect of poly(D,L-lactide-co-glycolide) microparticles with polyelectrolyte self-assembled multilayer surfaces on the cross-presentation of exogenous antigens. Yang YW; Hsu PY Biomaterials; 2008 Jun; 29(16):2516-26. PubMed ID: 18329708 [TBL] [Abstract][Full Text] [Related]
8. Dendritic cells process antigens encapsulated in a biodegradable polymer, poly(D,L-lactide-co-glycolide), via an alternate class I MHC processing pathway. Gerelchuluun T; Lee YH; Lee YR; Im SA; Song S; Park JS; Han K; Kim K; Lee CK Arch Pharm Res; 2007 Nov; 30(11):1440-6. PubMed ID: 18087813 [TBL] [Abstract][Full Text] [Related]
9. Functional characterization of biodegradable nanoparticles as antigen delivery system. Petrizzo A; Conte C; Tagliamonte M; Napolitano M; Bifulco K; Carriero V; De Stradis A; Tornesello ML; Buonaguro FM; Quaglia F; Buonaguro L J Exp Clin Cancer Res; 2015 Oct; 34():114. PubMed ID: 26444005 [TBL] [Abstract][Full Text] [Related]
10. Recruitment of bone marrow CD11b Yang YW; Luo WH Sci Rep; 2017 Mar; 7():44691. PubMed ID: 28317931 [TBL] [Abstract][Full Text] [Related]
11. A cell-penetrating peptide-assisted nanovaccine promotes antigen cross-presentation and anti-tumor immune response. Liu X; Liu J; Liu D; Han Y; Xu H; Liu L; Leng X; Kong D Biomater Sci; 2019 Dec; 7(12):5516-5527. PubMed ID: 31670734 [TBL] [Abstract][Full Text] [Related]
12. CD8- dendritic cells and macrophages cross-present poly(D,L-lactate-co-glycolate) acid microsphere-encapsulated antigen in vivo. Schliehe C; Redaelli C; Engelhardt S; Fehlings M; Mueller M; van Rooijen N; Thiry M; Hildner K; Weller H; Groettrup M J Immunol; 2011 Sep; 187(5):2112-21. PubMed ID: 21795597 [TBL] [Abstract][Full Text] [Related]
13. Nanovaccine Incorporated with Hydroxychloroquine Enhances Antigen Cross-Presentation and Promotes Antitumor Immune Responses. Liu J; Liu X; Han Y; Zhang J; Liu D; Ma G; Li C; Liu L; Kong D ACS Appl Mater Interfaces; 2018 Sep; 10(37):30983-30993. PubMed ID: 30136844 [TBL] [Abstract][Full Text] [Related]
14. Efficient scavenger receptor-mediated uptake and cross-presentation of negatively charged soluble antigens by dendritic cells. Shakushiro K; Yamasaki Y; Nishikawa M; Takakura Y Immunology; 2004 Jun; 112(2):211-8. PubMed ID: 15147564 [TBL] [Abstract][Full Text] [Related]
15. Carbohydrate-mediated targeting of antigen to dendritic cells leads to enhanced presentation of antigen to T cells. Adams EW; Ratner DM; Seeberger PH; Hacohen N Chembiochem; 2008 Jan; 9(2):294-303. PubMed ID: 18186095 [TBL] [Abstract][Full Text] [Related]
16. Differential use of autophagy by primary dendritic cells specialized in cross-presentation. Mintern JD; Macri C; Chin WJ; Panozza SE; Segura E; Patterson NL; Zeller P; Bourges D; Bedoui S; McMillan PJ; Idris A; Nowell CJ; Brown A; Radford KJ; Johnston AP; Villadangos JA Autophagy; 2015; 11(6):906-17. PubMed ID: 25950899 [TBL] [Abstract][Full Text] [Related]
17. Polymer nanoparticles for enhanced immune response: combined delivery of tumor antigen and small interference RNA for immunosuppressive gene to dendritic cells. Heo MB; Cho MY; Lim YT Acta Biomater; 2014 May; 10(5):2169-76. PubMed ID: 24394635 [TBL] [Abstract][Full Text] [Related]
18. Carbon monoxide decreases endosome-lysosome fusion and inhibits soluble antigen presentation by dendritic cells to T cells. Tardif V; Riquelme SA; Remy S; Carreño LJ; Cortés CM; Simon T; Hill M; Louvet C; Riedel CA; Blancou P; Bach JM; Chauveau C; Bueno SM; Anegon I; Kalergis AM Eur J Immunol; 2013 Nov; 43(11):2832-44. PubMed ID: 23852701 [TBL] [Abstract][Full Text] [Related]